Expression of the purported sigma1 (σ1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy

Journal of Chemical Neuroanatomy

Volumn 20, Issue 3-4, 2000, Pages 375-387

  Kitaichi, Kiyoyuki ^a   Chabot, Jean Guy ^a   Moebius, Fabian F ^b   Flandorfer, Astrid ^b   Glossmann, Hartmut ^b   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Amnesia model; Autoradiographic localization; Dizocilpine; Guinea pig; In situ hybridization; Man; Mouse

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTAZOCINE; SIGMA 1 OPIATE RECEPTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LEARNING DISORDER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING; RECEPTOR GENE; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

AMNESIA; ANALGESICS, OPIOID; ANIMALS; ANTISENSE ELEMENTS (GENETICS); AUTORADIOGRAPHY; BRAIN CHEMISTRY; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; GUINEA PIGS; HUMANS; IN SITU HYBRIDIZATION; MALE; MAMMALS; MICE; MICE, INBRED STRAINS; PENTAZOCINE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA; RNA, MESSENGER; TRITIUM;

EID: 0034469983     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(00)00106-X     Document Type: Article

References (81)

1. 1 receptor in the adult rat central nervous system
2. A decrease in angiotensin receptor binding in the rat brain nuclei by antisense oligonucleotides to the angiotensin AT1 receptor
3. 3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus
4. 3H](+)pentazocine binding sites in the rat brain: Autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes
5. Autoradiographic evidence for the modulation of in vivo sigma receptor labeling by neuropeptide Y and calcitonin gene-related peptide in the mouse brain
6. Neuropeptide Y and the calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a sigma receptor-related mechanism
7. In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: Radioligand binding and electrophysiological studies
8. Evidence for a multi-site model of the rat brain sigma receptor
9. 2 receptor affinity and subtype selectivity
10. 2 receptor-selective ligands with moderate affinity
11. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
12. NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain
13. Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization
14. Structure-activity relationships and evolution of sigma receptor ligands (1976-present)
15. Current hypotheses on sigma receptors and their physiological role: Possible implications in psychiatry
16. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disorders
17. Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures
18. Evidence for an anti-amnesic effect of JO-1784 in the rat: A potent and selective ligand for the sigma receptor
19. Functional and binding properties of sigma receptors in rat cerebellum
20. 1-binding site
21. sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion
22. Imaging sigma receptors and cerebral responses to sigma drugs
23. 3H]4-phenyl-1-(4-phenylbutyl)piperidine
24. Dopamine D-5 receptor modulates hippocampal acetylcholine release
25. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine
26. Multiple sigma binding sites in the brain
27. Expression of the neuropeptide Y Y1 receptor mRNA in the human brain: An in situ hybridization study
28. 3H]glutamate binding to NMDA receptors in human cerebellum
29. Autoradiographic distribution of sigma receptors in human neocortex, hippocampus, basal ganglia, cerebellum, pineal and pituitary gland
30. Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss
31. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)
32. Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor
33. 4, receptor supports its role as autoreceptors in the rat hippocampus
34. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
35. Sigma receptors are associated with cortical limbic areas in the primate brain
36. Ameliorating effects of σ receptor ligands on the impairment of passive avoidance task in mice: Involvement in the central acetylcholinergic system
37. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist
38. Similar ameliorating effects of benzomorphans and 5-HT2 antagonists and drug-induced impairment of passive avoidance response in mice: Comparison wit acetylcholinesterase inhibitors
39. 1 receptor agonistic properties
40. Inpursuitofantisense
41. Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands
42. SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice
43. Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors
44. 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism
45. Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM)
46. PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice
47. Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia
48. Low dose of 1,3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice
49. 2 sites
50. 3H]SKF 10.047 binding sites (sigma sites) from rat liver membranes
51. The mysteries of sigma receptors: New family members reveal a role in cholesterol synthesis
52. In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands
53. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors
54. The sigma receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia
55. Intrahippocampal administration of (+)-SKF 10 047, a sigma ligand, reverses MK-801-induced impairment of working memory in rats
56. 3H]NE-100 in guinea pig brain
57. Cloning and characterization of a mouse sigma1 receptor
58. Human brain receptor autoradiography using whole hemisphere sections: A general method that minimizes tissue artefacts
59. Classification and nomenclature of phencylidine and sigma receptor sites
60. A proposal for the classification of sigma binding sites
61. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats
62. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor
63. Cloning and functional characterization of a sigma receptor from rat brain
64. sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures
65. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor
66. Sigma receptors. Putative links between nervous, endocrine and immune systems
67. Delineating biochemical and functional properties of sigma receptors: Emerging concepts
68. Pharmacologic characterizations of sigma receptors
69. Sigma receptors in the central nervous system and the periphery
70. Sigma compounds derived from phencyclidine: Identification of PRE-084, a new, selective sigma ligand
71. Potential therapeutic application of sigma receptor antagonists
72. 1) receptors
73. The state of the art in antisense research
74. Sigma receptors: Biology and function
75. Role of sigma receptors in brain mechanisms of movement
76. Initial characterization and autoradiographic localization of a novel sigma/opioid binding site in immune tissues
77. Role of sigma binding sites in the modulation of endocrine and immune functions
78. Sigma-receptors in endocrine organs: Identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary
79. Differential localization of three distinct binding sites for sigma receptor ligands in rat spleen
80. Up-regulation of sigma(1) receptor mRNA in rat brain by a putative atypical antipsychotic and sigma receptor ligand
81. Sigma receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats